NCT06616688View on ClinicalTrials.gov

Innovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic Adenocarcinoma

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Pancreatic Ductal Adenocarcinoma (PDAC)

Interventions

OTHER

Organoid-guided treatment

After specimen removal as per clinical practice and pathological examination, a small piece of tumor tissue will be sent to the Axo-Glial Interaction Unit and cultured to build up organoid cultures

All Listed Sponsors

collaborator

National Nanotechnology Center (NANOTEC), The National Science and Technology Development Agency (NSTDA)

UNKNOWN

lead

IRCCS San Raffaele

OTHER

NCT06616688 - Innovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter